Anti-mycobacterials and Crohn's disease

被引：3

作者：

Chamberlin, W. M. ^{[1
]}

Shafran, I. ^{[1
]}

机构：

[1] Texas Tech Univ, Dept Med, El Paso, TX 79905 USA

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2008年 / 28卷 / 03期

关键词：

D O I：

10.1111/j.1365-2036.2008.03736.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页数：2

共 8 条

[1] Review article: the evidence base for interventions used to maintain remission in Crohn's disease [J].

Akobeng, A. K. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (01) :11-18

[2]

[Anonymous], Wikipedia

[3] Blood Cultures of 19 Crohn's Disease Patients [J].

Chamberlin, William ;

Naser, Saleh A. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (03) :802-803

[4] Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].

Hanauer, SB ;

Feagan, BG ;

Lichtenstein, GR ;

Mayer, LF ;

Schreiber, S ;

Colombel, JF ;

Rachmilewitz, D ;

Wolf, DC ;

Olson, A ;

Bao, WH ;

Rutgeerts, P .

LANCET, 2002, 359 (9317) :1541-1549

[5] Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease [J].

Naser, SA ;

Ghobrial, G ;

Romero, C ;

Valentine, JF .

LANCET, 2004, 364 (9439) :1039-1044

[6] Evidence based medicine: What it is and what it isn't - It's about integrating individual clinical expertise and the best external evidence [J].

Sackett, DL ;

Rosenberg, WMC ;

Gray, JAM ;

Haynes, RB ;

Richardson, WS .

BRITISH MEDICAL JOURNAL, 1996, 312 (7023) :71-72

[7] Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease [J].

Selby, Warwick ;

Pavli, Paul ;

Crotty, Brendan ;

Florin, Tim ;

Radford-Smith, Graham ;

Gibson, Peter ;

Mitchell, Brent ;

Connell, William ;

Read, Robert ;

Merrett, Michael ;

Ee, Hooi ;

Hetzel, David .

GASTROENTEROLOGY, 2007, 132 (07) :2313-2319

[8]

Tonelli M R, 2001, Respir Care, V46, P1435

← 1 →